CAS: 2222755-14-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LOXO-292 REF: IN-DA01V55UCAS: 2222755-14-6 | 99% | 168.00 €~468.00 € | Wed 11 Dec 24 |
 | RET-IN-1 REF: 3D-XND75514CAS: 2222755-14-6 | Min. 95% | To inquire | Wed 22 Jan 25 |
 | RET-IN-1 REF: TM-T16735CAS: 2222755-14-6 | 98% | 1,562.00 €~4,302.00 € | Wed 12 Mar 25 |
Ref: IN-DA01V55U
| 100mg | 168.00 € | ||
| 250mg | 468.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
RET-IN-1
CAS:2222755-14-6
RET-IN-1 is a peptide that activates the RET receptor tyrosine kinase. RET-IN-1 is an agonist …
Formula:
C29H31N9O3
Purity:
Min. 95%
Molecular weight:
553.6 g/mol
Ref: 3D-XND75514
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
RET-IN-1
CAS:2222755-14-6
RET-IN-1 is a RET kinase inhibitor (IC50s: 1 nM, 7 nM, and 101 nM for …
Formula:
C29H31N9O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
553.61
Ref: TM-T16735
| 25mg | 2,377.00 € | ||
| 50mg | 3,161.00 € | ||
| 100mg | 4,302.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025
